Cargando…
Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding
Cisplatin is a widely used anticancer drug, while non-targeted delivery, development of drug resistance, and serious side effects significantly limit its clinical use. In order to improve the tumor-targeting properties of cisplatin, transferrin (Tf) was employed as a carrier to transfer cisplatin in...
Autores principales: | Peng, Huifang, Jin, Hongwei, Zhuo, Huiqin, Huang, Heqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542211/ https://www.ncbi.nlm.nih.gov/pubmed/28484093 http://dx.doi.org/10.18632/oncotarget.17316 |
Ejemplares similares
-
The inhibitory effect of 6-gingerol and cisplatin on ovarian cancer and antitumor activity: In silico, in vitro, and in vivo
por: Salari, Zohreh, et al.
Publicado: (2023) -
Cisplatin
Binding to Human Serum Transferrin: A Crystallographic
Study
por: Troisi, Romualdo, et al.
Publicado: (2023) -
Serum and tissue proteomic signatures of patients with hepatocellular carcinoma using 2-D gel electrophoresis
por: Peng, Huifang, et al.
Publicado: (2019) -
Transferrin-Modified Nanoparticles for Photodynamic Therapy Enhance the Antitumor Efficacy of Hypocrellin A
por: Lin, Xi, et al.
Publicado: (2017) -
Effects of Hypoxia and Transferrin on Toxicity and DNA Binding of
Ruthenium Antitumor Agents in Hela Cells
por: Frasca, D., et al.
Publicado: (1996)